Key result
Socioeconomic status, social determinants of health, race, and ethnicity are associated with clinical outcomes in pulmonary arterial hypertension, though minorities remain underrepresented in trials.
Why the study?
Despite increasing awareness of socioeconomic status and race in pulmonary arterial hypertension outcomes, underrepresentation of minorities in clinical trials and registries remains.
This review highlights the significant impact of socioeconomic status, social determinants of health, and race/ethnicity on clinical outcomes in patients with pulmonary arterial hypertension.
Socioeconomic factors warrant assessment in PAH care; leaves open whether targeted interventions improve outcomes.
There is increasing awareness on the significance of socioeconomic status, social determinants of health, and the role of ethnicity and race in clinical outcomes of patients with pulmonary arterial hypertension. However, to date, underrepresentation of minorities in pulmonary hypertension clinical trials and registries remains. In the present review, we summarize the current knowledge on race, ethnicity, traditional and novel socioeconomics and social determinants of health, and its association with clinical outcomes in patients with pulmonary arterial hypertension. We present case examples on the interplay of these factors for specific disease phenotypes and discuss strategies for addressing these variables at the patient care level.
No takes yet. Share an insight, caveat, or question.
Bernardo et al. (2023) conducted a review in Pulmonary arterial hypertension. Socioeconomic status, social determinants of health, race, and ethnicity was evaluated on Clinical outcomes. Socioeconomic status, social determinants of health, race, and ethnicity are associated with clinical outcomes in pulmonary arterial hypertension, though minorities remain underrepresented in trials.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: